Document ID: chunk:federal_register_of_legislation:F2022C00926:clause:1_1:p3
Version: federal_register_of_legislation:F2022C00926
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 3/3)
Character Range: 20558–22451

= Federal Register of Legislation             rep = repealed
gaz = gazette                                   rs = repealed and substituted
LA = Legislation Act 2003                       s = section(s)/subsection(s)
LIA = Legislative Instruments Act 2003          Sch = Schedule(s)
(md) = misdescribed amendment can be given      Sdiv = Subdivision(s)
    effect                                      SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
    cannot be given effect                      Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
                                                    commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                  Registration     Commencement       Application, saving and transitional provisions
Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 76 of 2020)            2 November 2020  30 November 2020

                                                                                                      F2020L01395
Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022)  29 August 2022   19 September 2022

                                                                                                      F2022L01130

Endnote 4—Amendment history

Provision affected                                                   How affected
Section 2……………….                                                     rep LA s 48D
Section 4……………….                                                     rep LA s 48C
Subsection 9(5A)………                                                  ad No. 90 of 2022